← Leaderboards
Lewis A Chodosh
University Of Pennsylvania
$38,386,361
Attributed
$44,610,638
Total exposure
19
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,610,638 · 19
By mechanism
R01$30,639,819 · 12
U01$6,708,240 · 1
U54$2,619,780 · 2
U24$2,083,514 · 1
R33$2,059,713 · 1
P01$341,771 · 1
Top collaborators
- Angela Demichele5 shared
- Jerry D Glickson5 shared
- Despina Kontos5 shared
- Hank F Kung5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Nancy E. Cooke$14,296,597
- Hank F Kung$16,346,808
- Robert J Derubeis$8,551,105
- Jerry D Glickson$20,468,757
- Arjun G. Yodh$14,575,682
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsMalignant Breast NeoplasmRecurrenceNeoplastic CellCellsMouse ModelTumor ProgressionBiologyNeoplasm MetastasisPathway InteractionsGenetically Engineered MouseBaseCancer RecurrenceMolecularWomanCessation Of LifeGrowthResidual TumorsPrimary NeoplasmBiologicalResidual NeoplasmCancer EtiologyAnticancer Research
Grant awards (109)
In Vivo Oncogene-Induced Tumorigenesis and Escape$424,531
R01 · FY2025 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$424,531
R01 · FY2024 · CA · contact PI
Radiogenomic Biomarkers of Breast Cancer Recurrence$561,421
R01 · FY2022 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$374,728
R01 · FY2022 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$360,922
R01 · FY2022 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$634,332
R01 · FY2021 · CA · contact PI
Radiogenomic Biomarkers of Breast Cancer Recurrence$629,228
R01 · FY2021 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$382,375
R01 · FY2021 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$382,375
R01 · FY2021 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$368,288
R01 · FY2021 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$643,007
R01 · FY2020 · CA · contact PI
Radiogenomic Biomarkers of Breast Cancer Recurrence$642,591
R01 · FY2020 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$382,375
R01 · FY2020 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$382,375
R01 · FY2020 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$368,288
R01 · FY2020 · CA · contact PI
Radiogenomic Biomarkers of Breast Cancer Recurrence$634,978
R01 · FY2019 · CA
Secondary Prevention through Surveillance and Intervention$632,007
R01 · FY2019 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$370,903
R01 · FY2019 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$370,903
R01 · FY2019 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$357,238
R01 · FY2019 · CA · contact PI
Radiogenomic Biomarkers of Breast Cancer Recurrence$661,582
R01 · FY2018 · CA
Secondary Prevention through Surveillance and Intervention$660,057
R01 · FY2018 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$382,375
R01 · FY2018 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$382,375
R01 · FY2018 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$368,288
R01 · FY2018 · CA · contact PI
Secondary Prevention through Surveillance and Intervention$668,058
R01 · FY2017 · CA · contact PI
In Vivo Oncogene-Induced Tumorigenesis and Escape$382,375
R01 · FY2017 · CA · contact PI
Novel PET imaging agents for understanding glutamine addiction in cancer$811,646
R01 · FY2015 · CA
THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE$298,006
U54 · FY2015 · CA · contact PI
Developmental Research Core$228,824
U54 · FY2015 · CA · contact PI
Novel PET imaging agents for understanding glutamine addiction in cancer$788,514
R01 · FY2014 · CA
In Vivo Oncogene-induced Tumorigenesis and Escape$327,131
R01 · FY2014 · CA · contact PI
THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE$318,879
U54 · FY2014 · CA · contact PI
Role of SNF1 Kinase HUNK in breast cancer progression$312,379
R01 · FY2014 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$312,379
R01 · FY2014 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$312,379
R01 · FY2014 · CA · contact PI
Developmental Research Core$226,955
U54 · FY2014 · CA · contact PI
Novel PET imaging agents for understanding glutamine addiction in cancer$765,328
R01 · FY2013 · CA
Mechanisms of breast cancer progression$723,923
U01 · FY2013 · CA · contact PI
In Vivo Oncogene-induced Tumorigenesis and Escape$317,013
R01 · FY2013 · CA · contact PI
THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE$311,022
U54 · FY2013 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$302,718
R01 · FY2013 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$302,718
R01 · FY2013 · CA · contact PI
Role of SNF1 Kinase HUNK in breast cancer progression$302,718
R01 · FY2013 · CA · contact PI
Developmental Research Core$221,560
U54 · FY2013 · CA · contact PI
Novel PET imaging agents for understanding glutamine addiction in cancer$815,482
R01 · FY2012 · CA
Mechanisms of breast cancer progression$772,691
U01 · FY2012 · CA · contact PI
In Vivo Oncogene-induced Tumorigenesis and Escape$337,248
R01 · FY2012 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$322,040
R01 · FY2012 · CA · contact PI
Role of SNF1 Kinase HUNK in breast cancer progression$322,040
R01 · FY2012 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$322,040
R01 · FY2012 · CA · contact PI
THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE$321,337
U54 · FY2012 · CA · contact PI
Developmental Research Core$227,765
U54 · FY2012 · CA · contact PI
Novel PET imaging agents for understanding glutamine addiction in cancer$816,810
R01 · FY2011 · CA
Mechanisms of breast cancer progression$764,767
U01 · FY2011 · CA · contact PI
THE IMPACT OF EXERCISE AND CALORIC RESTRICTION ON CANCER RECURRENCE IN MICE$346,687
U54 · FY2011 · CA · contact PI
Penn Small Animal Imaging Resource (Penn-SAIR)$346,675
U24 · FY2011 · CA
In Vivo Oncogene-induced Tumorigenesis and Escape$337,248
R01 · FY2011 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$322,040
R01 · FY2011 · CA · contact PI
Role of SNF1 Kinase HUNK in breast cancer progression$322,040
R01 · FY2011 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$322,040
R01 · FY2011 · CA · contact PI
Developmental Research Core$118,745
U54 · FY2011 · CA · contact PI
Mechanisms of breast cancer progression$801,722
U01 · FY2010 · CA · contact PI
Penn Small Animal Imaging Resource (Penn-SAIR)$442,700
U24 · FY2010 · CA
In Vivo Oncogene-induced Tumorigenesis and Escape$347,135
R01 · FY2010 · CA · contact PI
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence$332,000
R01 · FY2010 · CA · contact PI
Survival and Recurrence of Dormant Cancer Cells$332,000
R01 · FY2010 · CA · contact PI
Role of SNF1 Kinase HUNK in breast cancer progression$330,790
R01 · FY2010 · CA · contact PI
Mechanisms of breast cancer progression$835,000
U01 · FY2009 · CA · contact PI
Penn Small Animal Imaging Resource (Penn-SAIR)$456,252
U24 · FY2009 · CA
Analysis of Tumor Dynamics in Progression and Metastasis$97,033
U01 · FY2009 · CA · contact PI
Analysis of Tumor Dynamics in Progression and Metastasis$544,744
U01 · FY2008 · CA · contact PI
Penn Small Animal Imaging Resource (Penn-SAIR)$457,562
U24 · FY2008 · CA
Analysis of Tumor Dynamics in Progression and Metastasis$541,731
U01 · FY2007 · CA · contact PI
Penn Small Animal Imaging Resource (Penn-SAIR)$380,325
U24 · FY2007 · CA
In Vivo Ras-induced Senescence and Tumorigenesis$334,387
R01 · FY2007 · CA · contact PI
Analysis of Tumor Dynamics in Progression and Metastasis$544,105
U01 · FY2006 · CA · contact PI
In Vivo Ras-induced Senescence and Tumorigenesis$344,375
R01 · FY2006 · CA · contact PI
Mechanisms of Progression in c-MYC-Induced Breast Cancer$344,375
R01 · FY2006 · CA · contact PI
Temporal Analysis of Mammary Carcinogenesis$693,098
R33 · FY2005 · CA
Analysis of Tumor Dynamics in Progression and Metastasis$543,220
U01 · FY2005 · CA
In Vivo Ras-induced Senescence and Tumorigenesis$352,663
R01 · FY2005 · CA
Mechanisms of Progression in c-MYC-Induced Breast Cancer$352,663
R01 · FY2005 · CA
Mammary Development and Breast Cancer Susceptibility$297,980
R01 · FY2005 · CA
Temporal Analysis of Mammary Carcinogenesis$689,619
R33 · FY2004 · CA
Analysis of Tumor Dynamics in Progression and Metastasis$539,304
U01 · FY2004 · CA
Mechanisms of Progression in c-MYC-Induced Breast Cancer$352,663
R01 · FY2004 · CA
In Vivo Ras-induced Senescence and Tumorigenesis$352,663
R01 · FY2004 · CA
Mammary Development and Breast Cancer Susceptibility$297,980
R01 · FY2004 · CA
HUNK AND PUNC FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$271,089
R01 · FY2004 · CA
Temporal Analysis of Mammary Carcinogenesis$676,996
R33 · FY2003 · CA
Mechanisms of Progression in c-MYC-Induced Breast Cancer$352,663
R01 · FY2003 · CA
In Vivo Ras-induced Senescence and Tumorigenesis$352,663
R01 · FY2003 · CA
Mammary Development and Breast Cancer Susceptibility$297,980
R01 · FY2003 · CA
HUNK AND PUNC FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$263,193
R01 · FY2003 · CA
Mechanisms of Progression in c-MYC-Induced Breast Cancer$352,663
R01 · FY2002 · CA
Mammary Development and Breast Cancer Susceptibility$297,980
R01 · FY2002 · CA
BRCA2 FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$271,159
R01 · FY2002 · CA
HUNK AND PUNC FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$255,530
R01 · FY2002 · CA
Temporal Analysis of Mammary Carcinogenesis$157,801
R21 · FY2002 · CA
MODULATION OF BREAST CANCER SUSCEPTIBILITY BY REPRODUCTIVE HISTORY$135,290
P01 · FY2002 · CA
Mammary Development and Breast Cancer Susceptibility$335,228
R01 · FY2001 · CA
BRCA2 FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$263,258
R01 · FY2001 · CA
HUNK AND PUNC FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$248,086
R01 · FY2001 · CA
MODULATION OF BREAST CANCER SUSCEPTIBILITY BY REPRODUCTIVE HISTORY$135,290
P01 · FY2001 · CA
BRCA1 AND DIFFERENTIATION AND ENDOCRINE RISK FACTOR$283,745
R01 · FY2000 · CA
BRCA2 FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$255,591
R01 · FY2000 · CA
HUNK AND PUNC FUNCTION IN MAMMARY EPITHELIAL BIOLOGY$240,860
R01 · FY2000 · CA
MODULATION OF BREAST CANCER SUSCEPTIBILITY BY REPRODUCTIVE HISTORY$71,191
P01 · FY2000 · CA